Because human plague is rare in most parts of the world, there is no need to vaccinate persons other than those at particularly high risk of exposure. Routine vaccination is not necessary for …

A plague vaccine is used for an induction of active specific immunity in an organism susceptible to plague by means of administrating an antigenic material (a vaccine) via a variety of routes to …

In this review, we summarize the latest advances in research and development of plague vaccines. Plague is caused by the facultative, intracellular Gram-negative bacterial pathogen, …

Feb 18, 2019 · In this review, we summarize the latest advances in research and development of plague vaccines. Plague is caused by the facultative, intracellular Gram-negative bacterial …

EV NIIEG is the only approved vaccine against plague for human use during plague outbreaks. The short-term immunity and the concern of safety are the limitations of this vaccine. …

We performed a systemic review of available randomised controlled trials (RCTs) of live, attenuated, or killed plague vaccines vs. placebo, no intervention, or other plague vaccine to …

May 15, 2024 · Note: A plague vaccine is no longer available in the United States. New plague vaccines are in development but are not expected to be commercially available in the …

Sep 7, 2024 · There is a compelling demand for approved plague vaccines due to the endemicity of Yersinia pestis and its potential for pandemic spread.

Plague vaccine should not be administered to persons who have a history of hypersensitivity to the vaccine or its components. Persons who have an acute febrile illness (e.g., influenza) …

Nov 1, 2023 · We performed a systemic review of available randomised controlled trials (RCTs) of live, attenuated, or killed plague vaccines vs. placebo, no intervention, or other plague vaccine …